The 12th Invest in ME Research Conference June, 2017, Part 2
MEMum presents the second article in a series of three about the recent 12th Invest In ME International Conference (IIMEC12) in London.
Discuss the article on the Forums.

Struggling Philadelphia biotech [Hemispherx] firm gets new CEO

Discussion in 'General ME/CFS News' started by Kati, Feb 27, 2016.

  1. Kati

    Kati Patient in training

    Messages:
    5,432
    Likes:
    19,357
    http://www.bizjournals.com/philadel...ngphiladelphia-biotech-firm-gets-new-ceo.html

    Exert:

    "The company is committed to a focused business plan oriented toward finding senior co-development partners with the capital and expertise needed to commercialize the many potential therapeutic aspects of our experimental drugs and our approved drug Alferon N. Management will make creating stockholder value and delivering much needed therapies to patients its prime objectives."
     
    CFS_for_19_years likes this.
  2. CFS_for_19_years

    CFS_for_19_years Hoarder of biscuits

    Messages:
    1,946
    Likes:
    4,887
    USA
    And in a related story:

    New Hemispherx (HEB) CEO Will Not Receive Salary for Two Months Until Stock Performs Better


    Read the rest of the story:
    http://www.biospace.com/News/new-hemispherx-ceo-will-not-receive-salary-for-two/412027
     
  3. Justin30

    Justin30 Senior Member

    Messages:
    1,065
    Likes:
    1,272
    Good for him, I respect that...this drug needs to make FDA approval and Dr Petterson and others need to define the patient cohort.
     

See more popular forum discussions.

Share This Page